As a Free StocksGuide user, you can view scores for all 7,079 stocks worldwide.
8 Analysts have issued a Fortress Biotech, Inc. forecast:
8 Analysts have issued a Fortress Biotech, Inc. forecast:
| Sep '25 |
+/-
%
|
||
| Revenue | 62 62 |
0%
0%
|
|
| Gross Profit | 45 45 |
18%
18%
|
|
| EBITDA | -56 -56 |
44%
44%
|
|
| EBIT (Operating Income) EBIT | -62 -62 |
40%
40%
|
|
| Net Profit | -5.34 -5.34 |
91%
91%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Fortress Biotech, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel pharmaceutical and biotechnology products. It operates through the following segments: Dermatology Product Sales and Pharmaceutical and Biotechnology Product Development. The company was founded on June 28, 2006 and is headquartered in New York, NY.
| Head office | United States |
| CEO | Lindsay Rosenwald |
| Employees | 101 |
| Founded | 2006 |
| Website | www.fortressbiotech.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


